Lineage Cell Therapeutics Files 2024 10-K
Ticker: LCTX · Form: 10-K · Filed: Mar 10, 2025 · CIK: 876343
| Field | Detail |
|---|---|
| Company | Lineage Cell Therapeutics, Inc. (LCTX) |
| Form Type | 10-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, biotechnology, financials
TL;DR
Lineage Cell Therapeutics filed its 2024 10-K, detailing financials and operations for the year ending Dec 31, 2024.
AI Summary
Lineage Cell Therapeutics, Inc. filed its 2024 10-K on March 10, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as BIOTIME INC, is based in Carlsbad, CA. Key financial details and operational highlights from the past fiscal year are detailed within this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Lineage Cell Therapeutics' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a biotechnology company, Lineage Cell Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2836 — SIC Code (Standard Industrial Classification for Biological Products)
- 943127919 — IRS Number (Company's IRS identification number)
- 001-12830 — SEC File Number (SEC's file number for the company)
Key Players & Entities
- Lineage Cell Therapeutics, Inc. (company) — Filer of the 10-K
- BIOTIME INC (company) — Former name of Lineage Cell Therapeutics, Inc.
- 2024-12-31 (date) — Fiscal year end date
- 2025-03-10 (date) — Filing date of the 10-K
- Carlsbad, CA (location) — Company's business and mailing address
FAQ
What is the primary business of Lineage Cell Therapeutics, Inc.?
Lineage Cell Therapeutics, Inc. is primarily involved in Biological Products (No Diagnostic Substances), as indicated by its SIC code 2836.
When was the company formerly known as?
The company was formerly known as BIOTIME INC, with a name change date of March 28, 1993.
Where is Lineage Cell Therapeutics, Inc. located?
The company's business and mailing address is 2173 Salk Avenue, Suite 200, Carlsbad, CA 92008.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
On what date was this 10-K filed with the SEC?
This 10-K was filed with the SEC on March 10, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 10, 2025 regarding Lineage Cell Therapeutics, Inc. (LCTX).